Načítá se...
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
Cell-based therapies are emerging as new promising treatments in stroke. However, their functional mechanism and therapeutic potential during early infarct maturation has so far received little attention. Here, we asked if cell-based delivery of the interleukin-1 receptor antagonist (IL-1Ra), a know...
Uloženo v:
| Vydáno v: | Acta Neuropathol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4835531/ https://ncbi.nlm.nih.gov/pubmed/26860727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-016-1541-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|